Quantitative Multiplex Methylation-Specific PCR Assay for the Detection of Promoter Hypermethylation in Multiple Genes in Breast Cancer
- 1 July 2004
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (13), 4442-4452
- https://doi.org/10.1158/0008-5472.can-03-3341
Abstract
If detected early, breast cancer is eminently curable. To detect breast cancer in samples with little cellularity, a high level of sensitivity is needed. Tumor-specific promoter hypermethylation has provided such a valuable tool for detection of cancer cells in biological samples. To accurately assess promoter hypermethylation for many genes simultaneously in small samples, we developed a novel method, quantitative multiplex-methylation-specific PCR (QM-MSP). QM-MSP is highly sensitive (1 in 104–105 copies of DNA) and linear over 5 orders of magnitude. For RASSF1A, TWIST, Cyclin D2, and HIN1, we observed significant differences in both the degree (P < 0.003) and incidence (P < 0.02) of hypermethylation between normal and malignant breast tissues. Evaluation of the cumulative hypermethylation of the four genes within each sample revealed a high level of sensitivity (84%) and specificity (89%) of detection of methylation. We demonstrate the application of this technique for detecting hypermethylated RASSF1A, TWIST, Cyclin D2, HIN1, and RARB in 50–1000 epithelial cells collected from breast ducts during endoscopy or by lavage. Such an approach could be used in a variety of small samples derived from different tissues, with these or different biomarkers to enhance detection of malignancy.Keywords
This publication has 32 references indexed in Scilit:
- Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancerInternational Journal of Cancer, 2003
- Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E‐cadherin and catenin expression and microsatellite instabilityInternational Journal of Cancer, 2003
- DNA methylation and breast carcinogenesisOncogene, 2002
- DNA methylation analysis: a powerful new tool for lung cancer diagnosisOncogene, 2002
- Quantitative Assessment of Promoter Hypermethylation during Breast Cancer DevelopmentThe American Journal of Pathology, 2002
- DNA Methylation Analysis by MethyLight TechnologyMethods, 2001
- The Hallmarks of CancerCell, 2000
- Validation of a Multiplex Methylation-sensitive PCR Assay for the Diagnosis of Prader-Willi and Angelman's SyndromesMolecular Diagnosis, 2000
- Loss of Heterozygosity in Normal Tissue Adjacent to Breast CarcinomasScience, 1996
- Aberrations of theAPC gene in primary breast carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1994